We are live on ! Find out more

493 hedge funds and large institutions have $12.7B invested in Sanofi in 2014 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 189 increasing their positions, 151 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more call options, than puts

Call options by funds: $47.5M | Put options by funds: $18.2M

25% more repeat investments, than reductions

Existing positions increased: 189 | Existing positions reduced: 151

2% more capital invested

Capital invested by funds: $12.5B → $12.7B (+$259M)

0.15% more ownership

Funds ownership: 17.98%18.13% (+0.15%)

1% less funds holding

Funds holding: 497493 (-4)

5% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 41

23% less funds holding in top 10

Funds holding in top 10: 1310 (-3)

Holders
493
Holders Change
-4
Holders Change %
-0.8%
% of All Funds
14.12%
Holding in Top 10
10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-23.08%
% of All Funds
0.29%
New
39
Increased
189
Reduced
151
Closed
41
Calls
$47.5M
Puts
$18.2M
Net Calls
+$29.2M
Net Calls Change
+$23.9M

SNY Hedge Fund Activity: Q2 2014 in Review

493 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2014, worth a combined $12.7B — up 2.1% from $12.5B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of SNY and 39 opened new positions — a net loss of 2 holders — while 151 trimmed existing stakes and 189 added.

The largest buyer was Franklin Resources, adding an estimated $209M. The largest seller was Boston Partners, cutting an estimated $259M.

  • 493 institutional investors held Sanofi (SNY) as of Q2 2014, down from 497 in Q1 2014.
  • Funds reported $12.7B of Sanofi stock for Q2 2014, up 2.1% quarter-over-quarter.
  • 39 funds opened new Sanofi positions in Q2 2014 and 41 closed out, a net change of -2 holders.
  • The largest Sanofi buyer in Q2 2014 was Franklin Resources, an estimated $209M added.
  • The largest Sanofi seller in Q2 2014 was Boston Partners, an estimated $259M sold.

Based on aggregated 13F filings for Q2 2014.